Maher, T. M., Mayes, M. D., Kreuter, M., Volkmann, E. R., Aringer, M., Castellvi, I., . . . Raghu, G. (2021). Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.), 73(4), 671-676. https://doi.org/10.1002/art.41576
Citace podle Chicago (17th ed.)Maher, Toby M., et al. "Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial." Arthritis & Rheumatology (Hoboken, N.J.) 73, no. 4 (2021): 671-676. https://doi.org/10.1002/art.41576.
Citace podle MLA (9th ed.)Maher, Toby M., et al. "Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial." Arthritis & Rheumatology (Hoboken, N.J.), vol. 73, no. 4, 2021, pp. 671-676, https://doi.org/10.1002/art.41576.